Author: Jesse Landry

Some companies raise capital. Others raise the temperature in a room that has been comfortable for far too long. Connect Music just pulled in $80M, led by Rockmont Partners and Variant Investments, and the number matters less than the signal. This is not money chasing nostalgia or streaming math that only works on a spreadsheet. This is capital betting that independent artists are done renting their futures. George Monger did not wake up one morning and decide to “disrupt” music. He grew up inside it, worked through it, watched who won and who got quiet. From opera to orchestras to…

In every city budget meeting, there is a quiet scene nobody streams. A room full of adults arguing about minutes. Minutes between a crash and a cruiser. Minutes between a flooded street and a stranded family. Minutes between a pothole report and a lawsuit. Public safety and community well-being eat about 70% of general fund budgets, and the stopwatch always wins. Urban SDK looked at that chaos and did something refreshingly unromantic. Turn the physical world into intelligence, then turn intelligence into action. Not a prettier dashboard for the sake of looking busy, but a SaaS system of action that…

Most people think flying is about confidence. White knuckles, checklists, bravado wrapped in aluminum. The truth is uglier and more human. Flying has always been about managing risk faster than fear can talk. That is the quiet tension Skyryse has been living in since 2016, when Dr. Mark Groden, CEO, decided aviation did not need more bravado. It needed fewer excuses. This week, Skyryse locked in $300M+ in Series C capital at a $1.15B valuation. The round was led by Autopilot Ventures and Fidelity Management & Research Company, with ArrowMark Partners returning and a deep bench that includes Atreides Management…

Accounting has always been a quiet grind. Fluorescent lights. Seasonality that eats weekends. Spreadsheets that feel like they were designed by someone who never met an actual human. And somehow, for decades, we called that normal. Efficient, even. Progress moves slow when the pain has been amortized across generations. Accrual just walked in and decided that was a lazy assumption. Coming out of stealth with $75M, Accrual is not pitching software. It is pitching relief. An AI-native accounting platform that treats tax preparation and review like a single, continuous thought instead of a relay race of handoffs, rework, and apologies.…

Pay With Spire just closed a $10M Series B led by Continental Investment Partners, and the volume is turned down on purpose. No confetti cannons. No chest beating. Just a clean signal from a fintech that has been living in the plumbing long enough to know where the pressure actually builds. Congratulations to Jennifer LaClair, CEO, and Vijay Patel, CTO, and to the team in Dallas that understands payments are not about novelty, they are about trust that survives Monday morning. Spire is an appropriate name. A spire points up, but it is anchored deep. This company came out of…

There is a certain moment in every wave of technology where the room gets quiet. Not because people are bored, but because something just crossed from theory into inevitability. Feltsense lives in that silence right now. A San Francisco company building AI agents that do not assist founders, do not copilote founders, but wake up every day as founders. Idea, product, customer, revenue. No applause track. Just execution. The seed round closed at $5.1M, led by Draper Associates with Precursor Ventures and Liquid2 Ventures stepping in like investors who have seen this movie before and paid attention during the second…

Insurance money has always been the quiet room in the building. Doors closed. Lights on late. Spreadsheets humming like bad neon. Everyone knows the premiums are moving, but no one can quite tell you where the friction lives or why so much value evaporates between collection and remittance. That silence is expensive. In 2024, Omer Rimoch and Gal Dreiman decided silence was the real risk, and they built Advance to make the money talk. Advance just closed an $8.55M seed round, announced February 5, 2026, led by NVP Capital with participation from Crystal Ventures, Vesey Ventures, Mensch Capital, and strategic…

There is a quiet arrogance in money that was never taught, only inherited. Alinea Invest exists because Anam Imran Lakhani and Eve Mathilde Louise Halimi clocked that early. Not as a complaint, not as a manifesto, but as an observation sharp enough to cut glass. When most finance apps talk down or dress fear up as sophistication, Alinea Invest speaks plainly, like someone who actually remembers the first time they Googled what a stock was and felt stupid for even asking. This week, Alinea Invest secured $22.5M in non-dilutive user acquisition financing from PvX Partners, the Singapore-based growth platform led…

The RNA wave has moved past theory and into consequence. Capital is flowing, clinical data is maturing, and the market is sorting out who is building science versus who is selling hope. In San Diego, ADARx Pharmaceuticals has been quietly doing the former since 2019, assembling a company that treats RNA like a precision instrument, not a blunt object. The global RNA therapeutics market is tracking from $20.32 billion in 2025 to $45.35 billion by 2034, but scale alone does not crown leaders. Execution does. ADARx Pharmaceuticals was founded by Dr. Zhen Li, a Harvard-trained chemist with decades of RNA…

Sixty-plus years in venture capital is not longevity by accident. Norwest Venture Partners started in 1961 in Minneapolis before Silicon Valley was mythology, before SaaS had a name, before patience became a competitive advantage. Today that same firm manages $15.5 billion, has backed more than 700 companies, and actively supports over 250 still in motion. This is not a moment fund. This is a compounding machine built for founders who think in chapters, not headlines. What separates Norwest Venture Partners is not volume, it is posture. They show up early at Seed, stay through Series A, and remain present when…